Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 324

1.

Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions.

Polizzotto MN, Chen G, Tressler RL, Godfrey C.

Drugs. 2015 Jul 30. [Epub ahead of print]

PMID:
26224205
2.

ADAPTA: A pilot randomised controlled trial of an alcohol-focused intervention versus a healthy living intervention for problem drinkers identified in a general hospital setting.

Watson JM, Fairhurst C, Li J, Tober G, Crosby H, Lloyd C, Godfrey C, Mdege ND, Dale V, Toner P, Parrott S, Raistrick D; ARiAS Research Group.

Drug Alcohol Depend. 2015 Jun 29. pii: S0376-8716(15)00329-4. doi: 10.1016/j.drugalcdep.2015.06.030. [Epub ahead of print]

3.

Guidance for conducting systematic scoping reviews.

Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB.

Int J Evid Based Healthc. 2015 Jul 1. [Epub ahead of print]

PMID:
26134548
4.

Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy.

Betts CA, Saleh AF, Carr CA, Muses S, Wells KE, Hammond SM, Godfrey C, McClorey G, Woffindale C, Clarke K, Wells DJ, Gait MJ, Wood MJ.

Sci Rep. 2015 Jun 26;5:11632. doi: 10.1038/srep11632.

5.

Pharmacological interventions for drug-using offenders.

Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Godfrey C, Hewitt C.

Cochrane Database Syst Rev. 2015 Jun 2;6:CD010862. [Epub ahead of print]

PMID:
26035084
6.

Interventions for drug-using offenders with co-occurring mental illness.

Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Godfrey C, Hewitt C.

Cochrane Database Syst Rev. 2015 Jun 2;6:CD010901. doi: 10.1002/14651858.CD010901.pub2.

PMID:
26034938
7.

How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse.

Godfrey C, Muses S, McClorey G, Wells KE, Coursindel T, Terry RL, Betts C, Hammond S, O'Donovan L, Hildyard J, El Andaloussi S, Gait MJ, Wood MJ, Wells DJ.

Hum Mol Genet. 2015 Aug 1;24(15):4225-37. doi: 10.1093/hmg/ddv155. Epub 2015 May 1.

PMID:
25935000
8.

A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries.

Forhan SE, Godfrey CC, Watts DH, Langley CL.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S350-6. doi: 10.1097/QAI.0000000000000488. Review.

PMID:
25768874
9.

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.

Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS; AIDS Clinical Trials Group (ACTG) A5257 Team; AIDS Clinical Trials Group ACTG A5257 Team.

Clin Infect Dis. 2015 Jun 15;60(12):1842-51. doi: 10.1093/cid/civ193. Epub 2015 Mar 12.

PMID:
25767256
10.

Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.

Betts CA, Saleh AF, Carr CA, Hammond SM, Coenen-Stass AM, Godfrey C, McClorey G, Varela MA, Roberts TC, Clarke K, Gait MJ, Wood MJ.

Sci Rep. 2015 Mar 11;5:8986. doi: 10.1038/srep08986.

11.

Delivery of therapeutic oligonucleotides with cell penetrating peptides.

Boisguérin P, Deshayes S, Gait MJ, O'Donovan L, Godfrey C, Betts CA, Wood MJ, Lebleu B.

Adv Drug Deliv Rev. 2015 Jun 29;87:52-67. doi: 10.1016/j.addr.2015.02.008. Epub 2015 Mar 4. Review.

PMID:
25747758
12.

Prevalence and predictors of externalizing behavior in young adult survivors of pediatric traumatic brain injury.

Ryan NP, Hughes N, Godfrey C, Rosema S, Catroppa C, Anderson VA.

J Head Trauma Rehabil. 2015 Mar-Apr;30(2):75-85. doi: 10.1097/HTR.0000000000000123.

PMID:
25734838
13.

Negotiating the 'grey area between normal social drinking and being a smelly tramp': a qualitative study of people searching for help online to reduce their drinking.

Khadjesari Z, Stevenson F, Godfrey C, Murray E.

Health Expect. 2015 Feb 12. doi: 10.1111/hex.12351. [Epub ahead of print]

PMID:
25676536
14.

Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).

Gross R, Zheng L, La Rosa A, Sun X, Rosenkranz SL, Cardoso SW, Ssali F, Camp R, Godfrey C, Cohn SE, Robbins GK, Chisada A, Wallis CL, Reynolds NR, Lu D, Safren SA, Hosey L, Severe P, Collier AC.

Lancet HIV. 2015 Jan 1;2(1):e12-e19.

PMID:
25664336
15.

Positive and negative behaviours in workplace relationships: a scoping review protocol.

Almost J, Wolff A, Mildon B, Price S, Godfrey C, Robinson S, Ross-White A, Mercado-Mallari S.

BMJ Open. 2015 Feb 4;5(2):e007685. doi: 10.1136/bmjopen-2015-007685.

16.

Does what we measure matter? Quality-of-life defined by adolescents with brain injury.

Di Battista A, Godfrey C, Soo C, Catroppa C, Anderson V.

Brain Inj. 2015;29(5):573-82. doi: 10.3109/02699052.2014.989905. Epub 2015 Feb 2.

PMID:
25642580
17.

The Trajectory of Long-Term Psychosocial Development 16 Years following Childhood Traumatic Brain Injury.

Rosema S, Muscara F, Anderson V, Godfrey C, Hearps S, Catroppa C.

J Neurotrauma. 2015 Jul 1;32(13):976-83. doi: 10.1089/neu.2014.3567. Epub 2015 Apr 10.

PMID:
25590265
18.

Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides.

Hammond SM, McClorey G, Nordin JZ, Godfrey C, Stenler S, Lennox KA, Smith CI, Jacobi AM, Varela MA, Lee Y, Behlke MA, Wood MJ, Andaloussi SE.

Mol Ther Nucleic Acids. 2014 Nov 25;3:e212. doi: 10.1038/mtna.2014.63.

19.

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS; ACTG A5257 Team.

Ann Intern Med. 2014 Oct 7;161(7):I-22. doi: 10.7326/P14-9035. No abstract available.

PMID:
25285557
20.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS; ACTG A5257 Team.

Ann Intern Med. 2014 Oct 7;161(7):461-71. doi: 10.7326/M14-1084. Erratum in: Ann Intern Med. 2014 Nov 4;161(9):680.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk